The TLCS Academy Webinar, “Personalized Pathways to Long-term Survival in EGFRm NSCLC,” brings together leading experts to explore advances in the management of EGFR-mutant non–small cell lung cancer, with a particular focus on the East Asian and Taiwan real-world landscape. The program will highlight evolving treatment strategies in the TKI era, addressing the challenges of long-term disease control and personalized care. Through expert lectures and the discussion, the webinar aims to translate real-world evidence and clinical experience into practical insights that support optimized, patient-centered outcomes in EGFRm NSCLC.